OncoCyte Ownership 2024 | Who Owns OncoCyte Now?

Overview Forecast RevenueFinancials Chart Transcripts

Institutional Ownership

13.94%

Insider Ownership

12.80%

Retail Ownership

73.26%

Institutional Holders

2.00

OncoCyte Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
AWM INVESTMENT COMPANY, INC.	13.28%	0.44%	1,097,175	342,889	45.46%	3,236,666	Jun 30, 2024
DEFENDER CAPITAL, LLC.	0.67%	0.06%	55,220	-665	-1.19%	162,899	Jun 30, 2024

OncoCyte's largest institutional shareholder is AWM INVESTMENT COMPANY, INC., holding 13.28% of the company's total share outstanding, currently valued at $3.24M. The top 10 institutional shareholders own together 13.94% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
AWM INVESTMENT COMPANY, INC.	13.28%	0.44%	1,097,175	342,889	45.46%	3,236,666	Jun 30, 2024
DEFENDER CAPITAL, LLC.	0.67%	0.06%	55,220	-665	-1.19%	162,899	Jun 30, 2024

The largest OncoCyte shareholder by % of total assets is AWM INVESTMENT COMPANY, INC.. The company owns 1.10M shares of OncoCyte (OCX), representing 0.44% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
AWM INVESTMENT COMPANY, INC.	13.28%	0.44%	1,097,175	342,889	45.46%	3,236,666	Jun 30, 2024
DEFENDER CAPITAL, LLC.	0.67%	0.06%	55,220	-665	-1.19%	162,899	Jun 30, 2024

As of Jun 30 2024, OncoCyte's largest institutional buyer is AWM INVESTMENT COMPANY, INC.. The company purchased 342.89K stocks of OCX, valued at $3.24M.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
DEFENDER CAPITAL, LLC.	0.67%	0.06%	55,220	-665	-1.19%	162,899	Jun 30, 2024
AWM INVESTMENT COMPANY, INC.	13.28%	0.44%	1,097,175	342,889	45.46%	3,236,666	Jun 30, 2024

As of Jun 30 2024, OncoCyte's biggest institutional seller is DEFENDER CAPITAL, LLC.. The company sold -0.67K shares of OCX, valued at $162.90K.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date

OncoCyte Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
VANGUARD VALLEY FORGE FUNDS	0.12%	63,657	-	-	Mar 31, 2024
BRIDGEWAY FUNDS INC	0.08%	200,000	-	-	Mar 28, 2024
FINANCIAL INVESTORS TRUST	0.03%	2,035,891	-	-	Jan 31, 2024
ETF Managers Trust	0.02%	157,933	-	-	Dec 31, 2023
QUANTITATIVE MASTER SERIES LLC	0.02%	110,088	-	-	Mar 31, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS	0.02%	10,247	-	-	Mar 31, 2024
TIAA SEPARATE ACCOUNT VA 1	0.01%	2,507	-	-	Mar 31, 2024
VANGUARD INDEX FUNDS	0.01%	4,181,409	-	-	Mar 31, 2024
TIAA-CREF LIFE FUNDS	0.01%	17,581	-	-	Mar 31, 2024
VANGUARD VALLEY FORGE FUNDS	0.01%	3,182	-	-	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	917,210	-	-	Feb 29, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS	0.00%	67,695	-	-	Mar 31, 2024
Calvert Variable Products, Inc.	0.00%	5,296	-	-	Mar 31, 2024
SCHWAB CAPITAL TRUST	0.00%	62,284	-	-	Feb 29, 2024
GPS Funds I	0.00%	7,151	-	-	Mar 31, 2024
SunAmerica Specialty Series	0.00%	519	-	-	Apr 30, 2021
PRUDENTIAL INVESTMENT PORTFOLIOS, INC.	0.00%	8,700	-	-	Mar 28, 2024
Voya VARIABLE PORTFOLIOS INC	0.00%	27,904	-	-	Mar 31, 2024
Global X Funds	0.00%	17,158	-	-	Jan 31, 2024
STATE STREET INSTITUTIONAL INVESTMENT TRUST	0.00%	22,185	-	-	Mar 31, 2024
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC	0.00%	1,668	-	-	Mar 31, 2024
TIAA-CREF FUNDS	0.00%	780,812	-	-	Mar 31, 2024
VANGUARD QUANTITATIVE FUNDS	0.00%	1,200	-	-	Mar 31, 2024
FLEXSHARES TRUST	0.00%	17,756	-	-	Jan 31, 2024
NORTHERN FUNDS	0.00%	32,058	-	-	Mar 28, 2024
COLLEGE RETIREMENT EQUITIES FUND	0.00%	226,593	-	-	Mar 31, 2024
HC CAPITAL TRUST	0.00%	5,805	-	-	Mar 31, 2024
RYDEX SERIES FUNDS	0.00%	574	-	-	Dec 31, 2023
SEI INSTITUTIONAL INTERNATIONAL TRUST	0.00%	1,872,964	-	-	Dec 31, 2023
FIDELITY SALEM STREET TRUST	0.00%	496,098	-	-	Mar 31, 2024
SA FUNDS INVESTMENT TRUST	0.00%	1,900	-	-	Mar 31, 2024
ProFunds	0.00%	1,286	-	-	Mar 31, 2024
VANGUARD SCOTTSDALE FUNDS	0.00%	213,504	-	-	Feb 29, 2024
T. Rowe Price Index Trust, Inc.	0.00%	2,321	-	-	Feb 29, 2024
PGIM ETF TRUST	0.00%	5,470	-	-	Feb 29, 2024
RYDEX DYNAMIC FUNDS	0.00%	317	-	-	Dec 31, 2023
VALIC Co I	0.00%	22,303	-	-	Feb 29, 2024
ALLSPRING MASTER TRUST	0.00%	4,192	-	-	Feb 29, 2024
PENN SERIES FUNDS INC	0.00%	1,800	-	-	Mar 28, 2024
Guggenheim Active Allocation Fund	0.00%	358	-	-	Feb 29, 2024
NATIONWIDE VARIABLE INSURANCE TRUST	0.00%	7,856	-	-	Mar 31, 2024
USAA MUTUAL FUNDS TRUST	0.00%	11,830	-	-	Jan 31, 2024
RYDEX VARIABLE TRUST	0.00%	58	-	-	Dec 31, 2023
VANGUARD WELLINGTON FUND	0.00%	19,280	-	-	Feb 29, 2024
Dimensional ETF Trust	0.00%	20,766	-	-	Jan 31, 2024
Meeder Funds	0.00%	195	-	-	Mar 31, 2024
PROSHARES TRUST	0.00%	9,976	-	-	Feb 29, 2024
NATIONWIDE MUTUAL FUNDS	0.00%	4,363	-	-	Jan 31, 2024
Brighthouse Funds Trust II	0.00%	28,960	-	-	Mar 31, 2024
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST	0.00%	57,637	-	-	Mar 31, 2024
ADVANCED SERIES TRUST	0.00%	75,700	-	-	Mar 28, 2024
ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST	0.00%	1,223	-	-	Dec 31, 2023
ETF Series Solutions	0.00%	384	-	-	Jan 31, 2024
SUNAMERICA SERIES TRUST	0.00%	6,635	-	-	Mar 31, 2024
MORGAN STANLEY PATHWAY FUNDS	0.00%	1,653	-	-	Feb 29, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST	0.00%	17,138	-	-	Mar 31, 2024
PACIFIC SELECT FUND	0.00%	28,668	-	-	Mar 31, 2024
Invesco Exchange-Traded Fund Trust II	0.00%	2,204	-	-	Jan 31, 2024
Dimensional ETF Trust	0.00%	3,082	-	-	Jan 31, 2024
MASSMUTUAL SELECT FUNDS	0.00%	4,457	-	-	Dec 31, 2023
USAA MUTUAL FUNDS TRUST	0.00%	833	-	-	Jan 31, 2024
Bridge Builder Trust	0.00%	12,751	-	-	Mar 31, 2024
DFA INVESTMENT DIMENSIONS GROUP INC	0.00%	2,723	-	-	Jan 31, 2024
EQ ADVISORS TRUST	0.00%	2,716	-	-	Mar 31, 2024
iSHARES TRUST	0.00%	31,115	-	-	Mar 31, 2024
Meeder Funds	0.00%	9	-	-	Mar 31, 2024
BlackRock Variable Series Funds, Inc.	0.00%	8,559	-	-	Mar 31, 2024
PRINCIPAL FUNDS, INC.	0.00%	9,751	-	-	Feb 29, 2024
BLACKROCK FUNDS	0.00%	9,205	-	-	Mar 28, 2024
Advisors' Inner Circle Fund III	0.00%	122	-	-	Jan 31, 2024
SEI INSTITUTIONAL INVESTMENTS TRUST	0.00%	17,794	-	-	Feb 29, 2024
WILSHIRE MUTUAL FUNDS INC	0.00%	210	-	-	Dec 31, 2023
DFA INVESTMENT DIMENSIONS GROUP INC	0.00%	447	447	-	Jan 31, 2024
John Hancock Funds II	0.00%	5,996	-	-	Feb 29, 2024
VanEck ETF Trust	0.00%	17,571	-	-	Jan 31, 2024

OncoCyte's largest mutual fund holder by % of total assets is "VANGUARD VALLEY FORGE FUNDS", owning 63.66K shares, compromising 0.12% of its total assets.

OncoCyte Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Jun, 24	2	-
31 Mar, 24	2	-
31 Dec, 23	2	-
30 Sep, 23	2	-95.74%
30 Jun, 23	47	-7.84%
31 Mar, 23	51	-10.53%
31 Dec, 22	57	-6.56%
30 Sep, 22	61	-12.86%
30 Jun, 22	70	-17.65%
31 Mar, 22	85	-5.56%
31 Dec, 21	90	-10.00%
30 Sep, 21	100	5.26%
30 Jun, 21	95	3.26%
31 Mar, 21	92	43.75%
31 Dec, 20	64	12.28%
30 Sep, 20	57	-9.52%
30 Jun, 20	63	14.55%
31 Mar, 20	55	3.77%
31 Dec, 19	53	-
30 Sep, 19	53	10.42%
30 Jun, 19	48	2.13%
31 Mar, 19	47	235.71%
31 Dec, 18	14	-33.33%
30 Sep, 18	21	-19.23%
30 Jun, 18	26	-21.21%
31 Mar, 18	33	-8.33%
31 Dec, 17	36	12.50%
30 Sep, 17	32	-5.88%
30 Jun, 17	34	25.93%
31 Mar, 17	27	3.85%
31 Dec, 16	26	23.81%
30 Sep, 16	21	-25.00%
30 Jun, 16	28	-22.22%
31 Mar, 16	36	800.00%
31 Dec, 15	4	-

As of 30 Jun 24, 2 institutions are holding OncoCyte's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Jun, 24	1,152,395	42.24%
31 Mar, 24	810,171	-1.91%
31 Dec, 23	825,936	-0.94%
30 Sep, 23	833,802	-99.09%
30 Jun, 23	91,824,895	64.98%
31 Mar, 23	55,657,631	-8.40%
31 Dec, 22	60,759,707	-8.16%
30 Sep, 22	66,154,931	-3.75%
30 Jun, 22	68,729,099	26.45%
31 Mar, 22	54,351,762	-1.95%
31 Dec, 21	55,431,734	-1.99%
30 Sep, 21	56,559,147	0.00%
30 Jun, 21	56,557,421	3.69%
31 Mar, 21	54,543,328	66.13%
31 Dec, 20	32,831,885	4.93%
30 Sep, 20	31,288,318	-5.46%
30 Jun, 20	33,095,782	19.62%
31 Mar, 20	27,667,133	6.85%
31 Dec, 19	25,893,584	36.65%
30 Sep, 19	18,948,736	19.00%
30 Jun, 19	15,923,897	-1.08%
31 Mar, 19	16,097,781	94.22%
31 Dec, 18	8,288,262	-4.80%
30 Sep, 18	8,706,031	-0.83%
30 Jun, 18	8,779,294	1.65%
31 Mar, 18	8,636,458	84.67%
31 Dec, 17	4,676,817	6.02%
30 Sep, 17	4,411,351	13.06%
30 Jun, 17	3,901,931	3.34%
31 Mar, 17	3,775,731	20.80%
31 Dec, 16	3,125,497	1.55%
30 Sep, 16	3,077,676	94.13%
30 Jun, 16	1,585,335	-5.11%
31 Mar, 16	1,670,697	52.69%
31 Dec, 15	1,094,163	-

OncoCyte (OCX) has 1.15M shares outstanding as of 30 Jun 24, up 42.24% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Jun, 24	13.94%	12.44%
31 Mar, 24	10.59%	10.58%
31 Dec, 23	10.00%	9.42%
30 Sep, 23	10.31%	0.17%
30 Jun, 23	77.07%	3.53%
31 Mar, 23	46.71%	1.55%
31 Dec, 22	54.84%	1.76%
30 Sep, 22	55.78%	1.51%
30 Jun, 22	60.80%	1.75%
31 Mar, 22	58.92%	1.52%
31 Dec, 21	62.34%	1.63%
30 Sep, 21	61.84%	1.56%
30 Jun, 21	63.01%	1.43%
31 Mar, 21	66.42%	2.64%
31 Dec, 20	50.14%	2.32%
30 Sep, 20	46.53%	1.84%
30 Jun, 20	50.27%	2.48%
31 Mar, 20	45.02%	1.99%
31 Dec, 19	47.51%	3.57%
30 Sep, 19	36.46%	3.88%
30 Jun, 19	30.64%	2.57%
31 Mar, 19	34.51%	7.20%
31 Dec, 18	21.90%	4.68%
30 Sep, 18	21.64%	4.21%
30 Jun, 18	22.68%	3.05%
31 Mar, 18	27.27%	11.37%
31 Dec, 17	15.49%	7.62%
30 Sep, 17	14.26%	8.09%
30 Jun, 17	13.27%	7.81%
31 Mar, 17	13.04%	11.00%
31 Dec, 16	10.89%	8.11%
30 Sep, 16	11.59%	29.81%
30 Jun, 16	6.23%	14.44%
31 Mar, 16	6.57%	24.22%
31 Dec, 15	5.21%	-

As of 30 Jun 24, OncoCyte is held by 13.94% institutional shareholders, representing a 12.44% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Jun, 24	1	-
31 Mar, 24	-	-100.00%
31 Dec, 23	1	-
30 Sep, 23	-	-100.00%
30 Jun, 23	19	216.67%
31 Mar, 23	6	-73.91%
31 Dec, 22	23	53.33%
30 Sep, 22	15	-44.44%
30 Jun, 22	27	3.85%
31 Mar, 22	26	-33.33%
31 Dec, 21	39	-27.78%
30 Sep, 21	54	28.57%
30 Jun, 21	42	-38.24%
31 Mar, 21	68	65.85%
31 Dec, 20	41	20.59%
30 Sep, 20	34	-22.73%
30 Jun, 20	44	46.67%
31 Mar, 20	30	30.43%
31 Dec, 19	23	-23.33%
30 Sep, 19	30	-
30 Jun, 19	30	-26.83%
31 Mar, 19	41	1266.67%
31 Dec, 18	3	-50.00%
30 Sep, 18	6	-40.00%
30 Jun, 18	10	-33.33%
31 Mar, 18	15	-28.57%
31 Dec, 17	21	61.54%
30 Sep, 17	13	-40.91%
30 Jun, 17	22	37.50%
31 Mar, 17	16	45.45%
31 Dec, 16	11	175.00%
30 Sep, 16	4	-63.64%
30 Jun, 16	11	-68.57%
31 Mar, 16	35	775.00%
31 Dec, 15	4	-

1 institutional shareholders have increased their position in OCX stock as of 30 Jun 24 compared to - in the previous quarter (a 0.00% increase).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Jun, 24	1	-
31 Mar, 24	1	-
31 Dec, 23	1	-50.00%
30 Sep, 23	2	-71.43%
30 Jun, 23	7	-61.11%
31 Mar, 23	18	-5.26%
31 Dec, 22	19	-13.64%
30 Sep, 22	22	-12.00%
30 Jun, 22	25	-24.24%
31 Mar, 22	33	13.79%
31 Dec, 21	29	3.57%
30 Sep, 21	28	-17.65%
30 Jun, 21	34	183.33%
31 Mar, 21	12	33.33%
31 Dec, 20	9	-25.00%
30 Sep, 20	12	9.09%
30 Jun, 20	11	-21.43%
31 Mar, 20	14	-26.32%
31 Dec, 19	19	18.75%
30 Sep, 19	16	23.08%
30 Jun, 19	13	-
31 Mar, 19	-	-100.00%
31 Dec, 18	3	-25.00%
30 Sep, 18	4	-63.64%
30 Jun, 18	11	37.50%
31 Mar, 18	8	166.67%
31 Dec, 17	3	-57.14%
30 Sep, 17	7	250.00%
30 Jun, 17	2	-33.33%
31 Mar, 17	3	50.00%
31 Dec, 16	2	-66.67%
30 Sep, 16	6	-33.33%
30 Jun, 16	9	-
31 Mar, 16	-	-
31 Dec, 15	-	-

1 institutional shareholders have reduced their position in OCX stock as of 30 Jun 24 compared to 1 in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Jun, 24	2	-	1,152,395	42.24%	13.94%	12.44%	1	-	1	-
31 Mar, 24	2	-	810,171	-1.91%	10.59%	10.58%	-	-100.00%	1	-
31 Dec, 23	2	-	825,936	-0.94%	10.00%	9.42%	1	-	1	-50.00%
30 Sep, 23	2	-95.74%	833,802	-99.09%	10.31%	0.17%	-	-100.00%	2	-71.43%
30 Jun, 23	47	-7.84%	91,824,895	64.98%	77.07%	3.53%	19	216.67%	7	-61.11%
31 Mar, 23	51	-10.53%	55,657,631	-8.40%	46.71%	1.55%	6	-73.91%	18	-5.26%
31 Dec, 22	57	-6.56%	60,759,707	-8.16%	54.84%	1.76%	23	53.33%	19	-13.64%
30 Sep, 22	61	-12.86%	66,154,931	-3.75%	55.78%	1.51%	15	-44.44%	22	-12.00%
30 Jun, 22	70	-17.65%	68,729,099	26.45%	60.80%	1.75%	27	3.85%	25	-24.24%
31 Mar, 22	85	-5.56%	54,351,762	-1.95%	58.92%	1.52%	26	-33.33%	33	13.79%
31 Dec, 21	90	-10.00%	55,431,734	-1.99%	62.34%	1.63%	39	-27.78%	29	3.57%
30 Sep, 21	100	5.26%	56,559,147	0.00%	61.84%	1.56%	54	28.57%	28	-17.65%
30 Jun, 21	95	3.26%	56,557,421	3.69%	63.01%	1.43%	42	-38.24%	34	183.33%
31 Mar, 21	92	43.75%	54,543,328	66.13%	66.42%	2.64%	68	65.85%	12	33.33%
31 Dec, 20	64	12.28%	32,831,885	4.93%	50.14%	2.32%	41	20.59%	9	-25.00%
30 Sep, 20	57	-9.52%	31,288,318	-5.46%	46.53%	1.84%	34	-22.73%	12	9.09%
30 Jun, 20	63	14.55%	33,095,782	19.62%	50.27%	2.48%	44	46.67%	11	-21.43%
31 Mar, 20	55	3.77%	27,667,133	6.85%	45.02%	1.99%	30	30.43%	14	-26.32%
31 Dec, 19	53	-	25,893,584	36.65%	47.51%	3.57%	23	-23.33%	19	18.75%
30 Sep, 19	53	10.42%	18,948,736	19.00%	36.46%	3.88%	30	-	16	23.08%
30 Jun, 19	48	2.13%	15,923,897	-1.08%	30.64%	2.57%	30	-26.83%	13	-
31 Mar, 19	47	235.71%	16,097,781	94.22%	34.51%	7.20%	41	1266.67%	-	-100.00%
31 Dec, 18	14	-33.33%	8,288,262	-4.80%	21.90%	4.68%	3	-50.00%	3	-25.00%
30 Sep, 18	21	-19.23%	8,706,031	-0.83%	21.64%	4.21%	6	-40.00%	4	-63.64%
30 Jun, 18	26	-21.21%	8,779,294	1.65%	22.68%	3.05%	10	-33.33%	11	37.50%
31 Mar, 18	33	-8.33%	8,636,458	84.67%	27.27%	11.37%	15	-28.57%	8	166.67%
31 Dec, 17	36	12.50%	4,676,817	6.02%	15.49%	7.62%	21	61.54%	3	-57.14%
30 Sep, 17	32	-5.88%	4,411,351	13.06%	14.26%	8.09%	13	-40.91%	7	250.00%
30 Jun, 17	34	25.93%	3,901,931	3.34%	13.27%	7.81%	22	37.50%	2	-33.33%
31 Mar, 17	27	3.85%	3,775,731	20.80%	13.04%	11.00%	16	45.45%	3	50.00%
31 Dec, 16	26	23.81%	3,125,497	1.55%	10.89%	8.11%	11	175.00%	2	-66.67%
30 Sep, 16	21	-25.00%	3,077,676	94.13%	11.59%	29.81%	4	-63.64%	6	-33.33%
30 Jun, 16	28	-22.22%	1,585,335	-5.11%	6.23%	14.44%	11	-68.57%	9	-
31 Mar, 16	36	800.00%	1,670,697	52.69%	6.57%	24.22%	35	775.00%	-	-
31 Dec, 15	4	-	1,094,163	-	5.21%	-	4	-	-	-

OncoCyte Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Apr 15, 2024	BROADWOOD PARTNERS, L.P.	10 percent owner	-	P-Purchase	Buy	2,420,000	$2.92	$7.06M	4,929,066
Apr 15, 2024	BROADWOOD PARTNERS, L.P.	10 percent owner	-	P-Purchase	Buy	-	-	-	4,929,066
Apr 15, 2024	Riggs Josh	director, officer	CEO and President	P-Purchase	Buy	3,390	$2.95	$10.00K	3,505
Apr 15, 2024	Arno Andrew	director	-	P-Purchase	Buy	33,898	$2.95	$100.00K	69,054

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Apr 15, 2024	BROADWOOD PARTNERS, L.P.	10 percent owner	-	P-Purchase	Buy	2,420,000	$2.92	$7.06M	4,929,066
Apr 15, 2024	BROADWOOD PARTNERS, L.P.	10 percent owner	-	P-Purchase	Buy	-	-	-	4,929,066
Apr 15, 2024	Riggs Josh	director, officer	CEO and President	P-Purchase	Buy	3,390	$2.95	$10.00K	3,505
Apr 15, 2024	Arno Andrew	director	-	P-Purchase	Buy	33,898	$2.95	$100.00K	69,054

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Apr 15, 2024	BROADWOOD PARTNERS, L.P.	10 percent owner	-	J-Other	Sell	-	$30.60	-	-
Jul 03, 2023	Gutfreund John Peter		-	J-Other	Sell	3,085,047	-	-	-
Jul 03, 2023	Gutfreund John Peter		-	J-Other	Sell	3,564,728	$1.53	$5.45M	-

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jul 03, 2024	Arno Andrew	director	-	A-Award	Buy	30,000	$2.95	$88.50K	30,000
Jul 03, 2024	Last Andrew J.	director	-	A-Award	Buy	30,000	$2.95	$88.50K	30,000
Jul 03, 2024	SILVERMAN LOU	director	-	A-Award	Buy	30,000	$2.95	$88.50K	30,000
Jun 24, 2024	James Andrea S.	officer	Chief Financial Officer	A-Award	Buy	100,000	-	-	300,000
Jun 24, 2024	James Andrea S.	officer	Chief Financial Officer	A-Award	Buy	200,000	$2.87	$574.00K	200,000
Jun 24, 2024	James Andrea S.	officer	-		Buy	-	-	-	-
May 22, 2024	Liu James Yang	officer	Sr Dir., Cntlr, PAO, Int PFO	A-Award	Buy	10,000	$2.76	$27.60K	10,000
May 22, 2024	Arno Andrew	director	-	A-Award	Buy	20,000	$2.76	$55.20K	20,000
May 22, 2024	Riggs Josh	director, officer	CEO and President	A-Award	Buy	90,000	$2.76	$248.40K	90,000
Apr 15, 2024	BROADWOOD PARTNERS, L.P.	10 percent owner	-	P-Purchase	Buy	2,420,000	$2.92	$7.06M	4,929,066
Apr 15, 2024	BROADWOOD PARTNERS, L.P.	10 percent owner	-	P-Purchase	Buy	-	-	-	4,929,066
Apr 15, 2024	BROADWOOD PARTNERS, L.P.	10 percent owner	-	J-Other	Sell	-	$30.60	-	-
Apr 15, 2024	Riggs Josh	director, officer	CEO and President	P-Purchase	Buy	3,390	$2.95	$10.00K	3,505
Apr 15, 2024	Arno Andrew	director	-	P-Purchase	Buy	33,898	$2.95	$100.00K	69,054
Oct 12, 2023	Liu James Yang	officer	Sr Dir Controller PAO Int PFO	A-Award	Buy	8,482	$3.11	$26.38K	8,482
Aug 17, 2023	Riggs Josh	director, officer	CEO and President	A-Award	Buy	40,000	$3.34	$133.60K	40,000
Jul 03, 2023	Gutfreund John Peter		-	J-Other	Sell	3,085,047	-	-	-
Jul 03, 2023	Gutfreund John Peter		-	J-Other	Sell	3,564,728	$1.53	$5.45M	-
Jun 27, 2023	Arno Andrew	director	-	A-Award	Buy	30,000	-	-	703,133
Jun 27, 2023	Arno Andrew	director	-	A-Award	Buy	135,000	$0.20	$27.00K	135,000

The last insider sell of OncoCyte's stock was made by BROADWOOD PARTNERS, L.P. on Apr 15 2024, selling - shares at $30.60 per share (valued at -). The last insider buy of OCX was made by BROADWOOD PARTNERS, L.P. on Apr 15 2024, buying 2,420,000 shares at $2.92 per share (worth $7.06M).

OncoCyte Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q3 2024	3	-	-
Q2 2024	9	1	900.00%
Q4 2023	1	2	50.00%
Q3 2023	1	-	-
Q2 2023	18	3	600.00%
Q1 2023	5	3	166.67%
Q4 2022	6	14	42.86%
Q3 2022	21	1	2100.00%
Q2 2022	38	11	345.45%
Q1 2022	18	-	-
Q4 2021	-	1	-
Q3 2021	4	5	80.00%
Q2 2021	17	5	340.00%
Q1 2021	9	-	-
Q4 2020	17	4	425.00%
Q3 2020	6	-	-
Q2 2020	10	1	1000.00%
Q1 2020	14	4	350.00%
Q4 2019	2	-	-
Q3 2019	14	4	350.00%

3 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by OncoCyte's insiders, as of Q3 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q3 2024	-	-	-
Q2 2024	4	-	-
Q4 2023	-	-	-
Q3 2023	-	-	-
Q2 2023	4	-	-
Q1 2023	-	-	-
Q4 2022	3	-	-
Q3 2022	9	-	-
Q2 2022	28	6	466.67%
Q1 2022	6	-	-
Q4 2021	-	-	-
Q3 2021	-	-	-
Q2 2021	-	-	-
Q1 2021	5	-	-
Q4 2020	-	4	-
Q3 2020	6	-	-
Q2 2020	2	-	-
Q1 2020	9	1	900.00%
Q4 2019	2	-	-
Q3 2019	8	2	400.00%

As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of OncoCyte's stocks.

OncoCyte Peer Ownership

Ticker	Company
GTH	Genetron Holdings Limited
PSNL	Personalis, Inc.
PRPH	ProPhase Labs, Inc.
XGN	Exagen Inc.
SERA	Sera Prognostics, Inc.
BNR	Burning Rock Biotech Limited
ISPC	iSpecimen Inc.
CSTL	Castle Biosciences, Inc.
DRIO	DarioHealth Corp.
OLK	Olink Holding AB (publ)
BDSX	Biodesix, Inc.
FONR	FONAR Corporation
INBS	Intelligent Bio Solutions Inc.
PRPO	Precipio, Inc.
TRIB	Trinity Biotech plc
STIM	Neuronetics, Inc.
SHC	Sotera Health Company

OCX Ownership FAQ

Who Owns OncoCyte?

OncoCyte is owned by institutional shareholders (13.94%), insiders (12.80%), and public (73.26%). The largest institutional shareholder of OncoCyte is AWM INVESTMENT COMPANY, INC. (13.28% of total shares) and the top mutual fund owner is VANGUARD VALLEY FORGE FUNDS (0.12% of total shares).

Who are the major institutional shareholders of OncoCyte?

OncoCyte's major institutional shareholders are AWM INVESTMENT COMPANY, INC., and DEFENDER CAPITAL, LLC.. The top five shareholders own together 13.94% of the company's share outstanding.

How many OncoCyte shareholders are there?

As of Jun 2024, there are 2 institutional shareholders of OncoCyte.

What percentage of OncoCyte is owned by AWM INVESTMENT COMPANY, INC?

AWM INVESTMENT COMPANY, INC owns 1.1M shares of OncoCyte, representing 13.28% of the company's total shares outstanding, valued at $3.24M (as of Jun 2024).

What percentage of OncoCyte is owned by DEFENDER CAPITAL, LLC?

As of Jun 2024, DEFENDER CAPITAL, LLC holds 55.22K shares of OncoCyte (OCX), compromising 0.67% of the company, valued at $162.9K.